Lakes BioScience plans UK mAbs manufacturing facility
A FAST response UK biopharmaceutical manufacturing and process development factory which could help in the fight against Covid-19 and future pandemics is being planned by a partnership of pharma industry experts. Lakes BioScience Ltd, formed 18 months ago from a collaboration of an industry-connected executive team promising a fast, agile, customer-focused approach, is accelerating plans due to global demand for monoclonal antibodies production.Pat McIver, one of the founding directors of Lakes BioScience Ltd with more than 30 years of senior-level pharma industry experience, said: “